Delivery Order SPE2DB25D3017-SPE2DB26FVGSA
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,176.86 firm fixed-price delivery order is for the supply of EXJADE 500 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,684.20 firm fixed-price delivery order is for the provision of 4558286473 EXJADE 500 MG TABLET 30S, with a completion date of September 21, 2022. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This delivery order for $8,415.92, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for 4562667144 Exjade 500 mg tablets (30 tablets per package) to be delivered by November 15, 2023. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania. No set-aside designation was used for this award placed against an existing vehicle by the Defense Logistics Agency to procure pharmaceutical products in support of military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,451.24 Firm Fixed Price Delivery Order is for the supply of EXJADE 500 MG TABLET 30S, a pharmaceutical product, with a period of performance through November 16, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $40,176.29 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of JADENU 360 mg tablets (30-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical sourcing and distribution company. The $15,323.96 order is for the delivery of EXJADE 500 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of January 24, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp has a strong track record of providing...
- The Defense Logistics Agency awarded a delivery order valued at $84,982.81 to AmerisourceBergen Drug Corp for the supply of Jadenu 360 mg tablets (30-count units) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $17,333.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be performed at AmerisourceBergen's...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,490.00 by the Defense Logistics Agency's Medical Supply Chain for the supply of Jadenu 360 mg tablets (30-count units). The award, issued on June 2, 2025, with a completion date of June 3, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The point of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB26FVGSADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Exjade 500 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $16,027.08, is scheduled for completion by November 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability in federal pharmaceutical procurement. This delivery order is a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare systems and other government agencies. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 10/21/25 |